Financial insights of DBD

MyFinsight

For the quarter ending 2026-03-31, DBD made $891,800K in revenue. $5,000K in net income. Net profit margin of 0.56%.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total revenues (note 5)	891,800	1,104,200	945,200	915,200
Service	416,100	469,850*	408,400	412,000
Product	262,600	354,650*	291,700	269,200
Total cost of sales	678,700	824,500	700,100	681,200
Gross profit	213,100	279,700	245,100	234,000
Selling and administrative expense	157,200	175,600	150,900	154,200
Research, development and engineering expense	22,100	21,300	20,300	22,400
Impairment of assets and other	-	-400	-	-
Other operating expense (income)	-1,100	-	-100	-1,200
Total costs and expenses	180,400	197,300	171,300	177,800
Operating profit	32,700	82,400	73,800	56,200
Interest income	2,900	2,800	2,100	2,500
Interest expense	23,300	20,600	21,800	21,800
Foreign exchange, net	-2,400	-2,600	-800	-22,200
Reorganization items, net	-	0*	-	-
Miscellaneous, net	2,500	900	-900	2,500
Loss on extinguishment of debt	-	0*	-	-
Income (loss) before taxes	12,400	62,900	52,400	17,200
Income tax expense (benefit) (note 8)	5,700	11,900	9,600	4,800
Equity in loss of unconsolidated subsidiaries, net	-1,200	-400	-1,100	300
Net income (loss)	5,500	50,600	41,700	12,700
Net income attributable to noncontrolling interests	500	1,000	600	500
Net income (loss) attributable to diebold nixdorf	5,000	49,600	41,100	12,200

Basic EPS	0.14	1.382	1.13	0.33
Diluted EPS	0.14	1.351	1.11	0.33
Basic Average Shares	35,100,000	35,900,000	36,500,000	37,200,000
Diluted Average Shares	35,700,000	36,700,000	37,000,000	37,500,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.